<![CDATA[Sequencing CELMoDs With BsAbs and CAR T as a 'Sandwich Strategy' in Multiple Myeloma]]>

Summary

Medical experts discuss a combination treatment strategy using CELMoDs with bispecific antibodies and CAR T cells as a sequential approach for relapsed/refractory multiple myeloma. This is an educational discussion piece without new clinical data or announcements.